Half-year report · Q2

Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥31.4bn2024-06-01 → 2024-11-30Cons.Net sales
Revenue¥61.6bn2023-06-01 → 2024-05-31Cons.Net sales (5-year summary)
Revenue¥28.9bn2023-06-01 → 2023-11-30Cons.Net sales
Operating income¥522m2024-06-01 → 2024-11-30Cons.Operating income
Operating income¥618m2023-06-01 → 2023-11-30Cons.Operating income
Ordinary income¥552m2024-06-01 → 2024-11-30Cons.Ordinary income
Ordinary income¥1.0bn2023-06-01 → 2024-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥645m2023-06-01 → 2023-11-30Cons.Ordinary income
Profit before tax¥586m2024-06-01 → 2024-11-30Cons.Income before income taxes
Profit before tax¥700m2023-06-01 → 2023-11-30Cons.Income before income taxes
Net income (owners)¥338m2024-06-01 → 2024-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥580m2023-06-01 → 2024-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥480m2023-06-01 → 2023-11-30Cons.Profit loss attributable to owners of parent
Net income¥337m2024-06-01 → 2024-11-30Cons.Profit loss
Net income¥477m2023-06-01 → 2023-11-30Cons.Profit loss
Total assets¥26.4bnat 2024-11-30Cons.Assets
Total assets¥26.6bnat 2024-05-31Cons.Assets
Total assets¥24.8bnat 2023-11-30Cons.Total assets (5-year summary)
Total liabilities¥17.7bnat 2024-11-30Cons.Liabilities
Total liabilities¥18.0bnat 2024-05-31Cons.Liabilities
Net assets / equity¥8.7bnat 2024-11-30Cons.Net assets
Net assets / equity¥8.6bnat 2024-05-31Cons.Net assets
Net assets / equity¥8.3bnat 2023-11-30Cons.Net assets (5-year summary)
Cash and deposits¥4.4bnat 2024-11-30Cons.Cash and deposits
Cash and deposits¥5.3bnat 2024-05-31Cons.Cash and deposits
Cash & equivalents¥4.4bnat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥5.3bnat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥5.0bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥5.8bnat 2023-05-31dCons.Cash and cash equivalents
Operating cash flow−¥633m2024-06-01 → 2024-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥878m2023-06-01 → 2024-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥544m2023-06-01 → 2023-11-30Cons.Net cash provided by used in operating activities
Investing cash flow¥19m2024-06-01 → 2024-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2023-06-01 → 2024-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥154m2023-06-01 → 2023-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥239m2024-06-01 → 2024-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥335m2023-06-01 → 2024-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥123m2023-06-01 → 2023-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥136.82024-06-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥227.962023-06-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥188.052023-06-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio32.9%at 2024-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio32.2%at 2024-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.5%at 2023-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-06-01 → 2024-11-30¥0
Reconciling Itemsreconcilingrevenue intersegment2024-06-01 → 2024-11-30¥0
Reconciling Itemsreconcilingsegment profit2024-06-01 → 2024-11-30−¥519m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2024-06-01 → 2024-11-30¥113m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2024-06-01 → 2024-11-30¥112m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2024-06-01 → 2024-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2024-06-01 → 2024-11-30−¥82m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2024-06-01 → 2024-11-30¥31.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2024-06-01 → 2024-11-30¥31.2bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2024-06-01 → 2024-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2024-06-01 → 2024-11-30¥1.1bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2024-06-01 → 2024-11-30¥35m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2024-06-01 → 2024-11-30¥35m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2024-06-01 → 2024-11-30¥0
—segment totalrevenue2024-06-01 → 2024-11-30¥31.4bn
—segment totalrevenue external2024-06-01 → 2024-11-30¥31.4bn
—segment totalrevenue intersegment2024-06-01 → 2024-11-30¥0
—segment totalsegment profit2024-06-01 → 2024-11-30¥1.0bn
Reconciling Itemsreconcilingrevenue2023-06-01 → 2023-11-30¥0
Reconciling Itemsreconcilingrevenue intersegment2023-06-01 → 2023-11-30¥0
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2023-11-30−¥494m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2023-06-01 → 2023-11-30¥146m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2023-06-01 → 2023-11-30¥146m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2023-06-01 → 2023-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2023-06-01 → 2023-11-30¥6m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2023-06-01 → 2023-11-30¥28.7bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2023-06-01 → 2023-11-30¥28.7bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2023-06-01 → 2023-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2023-06-01 → 2023-11-30¥1.1bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2023-06-01 → 2023-11-30¥36m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2023-06-01 → 2023-11-30¥36m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2023-06-01 → 2023-11-30¥2m
—segment totalrevenue2023-06-01 → 2023-11-30¥28.9bn
—segment totalrevenue external2023-06-01 → 2023-11-30¥28.9bn
—segment totalrevenue intersegment2023-06-01 → 2023-11-30¥0
—segment totalsegment profit2023-06-01 → 2023-11-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 485
ItemContextValueUnit
Buildings and structuresPrior1YearInstant3074000000JPY
Buildings and structuresCurrentQuarterInstant3075000000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-1730000000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-1787000000JPY
Buildings and structures netPrior1YearInstant1343000000JPY
Buildings and structures netCurrentQuarterInstant1287000000JPY
LandPrior1YearInstant1687000000JPY
LandCurrentQuarterInstant1975000000JPY
Other ppePrior1YearInstant790000000JPY
Other ppeCurrentQuarterInstant803000000JPY
Accumulated depreciation other ppePrior1YearInstant-674000000JPY
Accumulated depreciation other ppeCurrentQuarterInstant-697000000JPY
Other net ppePrior1YearInstant116000000JPY
Other net ppeCurrentQuarterInstant105000000JPY
Property plant and equipmentPrior1YearInstant3147000000JPY
Property plant and equipmentCurrentQuarterInstant3368000000JPY
GoodwillPrior1YearInstant292000000JPY
GoodwillCurrentQuarterInstant315000000JPY
Other iaPrior1YearInstant45000000JPY
Other iaCurrentQuarterInstant40000000JPY
Intangible assetsPrior1YearInstant338000000JPY
Intangible assetsCurrentQuarterInstant356000000JPY
Investment securitiesPrior1YearInstant1267000000JPY
Investment securitiesCurrentQuarterInstant1326000000JPY
Stocks of subsidiaries and affiliatesPrior1YearInstant16000000JPY
Stocks of subsidiaries and affiliatesCurrentQuarterInstant-JPY
Claims provable in bankruptcy claims provable in rehabilitation and otherPrior1YearInstant597000000JPY
Claims provable in bankruptcy claims provable in rehabilitation and otherCurrentQuarterInstant561000000JPY
Net defined benefit assetPrior1YearInstant12000000JPY
Net defined benefit assetCurrentQuarterInstant20000000JPY
Other ioaPrior1YearInstant888000000JPY
Other ioaCurrentQuarterInstant534000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-597000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-561000000JPY
Investments and other assetsPrior1YearInstant2184000000JPY
Investments and other assetsCurrentQuarterInstant1882000000JPY
Noncurrent assetsPrior1YearInstant5670000000JPY
Noncurrent assetsCurrentQuarterInstant5606000000JPY
AssetsPrior1YearInstant26557000000JPY
AssetsCurrentQuarterInstant26442000000JPY
Notes and accounts payable tradePrior1YearInstant8282000000JPY
Notes and accounts payable tradeCurrentQuarterInstant9199000000JPY
Electronically recorded obligations operating clPrior1YearInstant7640000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant6985000000JPY
Income taxes payablePrior1YearInstant213000000JPY
Income taxes payableCurrentQuarterInstant68000000JPY
Provision for bonusesPrior1YearInstant700000000JPY
Provision for bonusesCurrentQuarterInstant213000000JPY
Other clPrior1YearInstant747000000JPY
Other clCurrentQuarterInstant680000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-05-31pass rounding
balance sheet identityconsolidated 2024-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-05-31pass
statement vs summary · net assetsconsolidated 2024-11-30pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2023-11-30pass
statement vs summary · net income attributable to parentconsolidated 2024-06-01/2024-11-30pass
statement vs summary · operating cash flowconsolidated 2023-06-01/2023-11-30pass
statement vs summary · operating cash flowconsolidated 2024-06-01/2024-11-30pass
statement vs summary · revenueconsolidated 2023-06-01/2023-11-30pass
statement vs summary · revenueconsolidated 2024-06-01/2024-11-30pass
statement vs summary · total assetsconsolidated 2024-05-31pass
statement vs summary · total assetsconsolidated 2024-11-30pass